Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Patent
1995-12-21
1999-01-12
Witz, Jean C.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
4352529, 435854, 435853, C12N 120
Patent
active
058583564
ABSTRACT:
Cryptosporidium parvum (the cause of cryptosporidiosis) has become one of the most common enteropathogens causing diarrhea worldwide. Symptoms associated with cryptosporidiosis are very debilitating especially in the immunocompromised subject (e.g., AIDS patient). Clinical features include severe, chronic diarrhea, abdominal cramps, fatigue, weight loss, etc. which lead to increased health care costs and increased mortality. There is described herein a method of inhibiting the severity of Cryptosporidium parvum infection by enterally administering a therapeutically effective amount of Lactobacillus acidophilus.
REFERENCES:
patent: 5318979 (1994-06-01), Davis
patent: 5443826 (1995-08-01), Borody
patent: 5531988 (1996-07-01), Paul
patent: 5531989 (1996-07-01), Paul
Petersen, "Cryptosporidiosis in Patients Infected with the Human Immunodeficiency Virus", Clinical Infectious Diseases, 15:903-909, 1992.
Laughon et al., "Summary of the Workshop on Future Directions in Discovery and Development of Therapeutic Agents for Opportunistic Infections Associated with Aids", The Journal of Infectious Diseases, 164:244-251, 1991.
Navarreta et al., "An Outbreak of Cryptosporidium Diarrhea in a Pediatric Hospital", The Pediatric Infectious Disease Journal, 10:;248-250, 1991.
Anonymous, "Cryptosporidiosis among Children Attending Day-Care Centers -Georgia, Pennsylvania, Michigan, California, New Mexico", Morbid Mortal. 33:599-601, 1984.
MacKenzie et al., "A Massive Outbreak in Milwaukee of Cryptosporidium Infection Transmitted Through the Public Water Supply", New England Journal of Medicine, 331:161-167, 1994.
Fayer and Ungar, "Cryptosporidium spp. and Cryptosporidiosis", Microbiological Reviews, 50:458-483, 1986.
Current, "The Biology of Cryptosporidiuim," ASM News, 54:605-611, 1988.
Schwartz et al., "Biliary Cryptosporidiosis in HIV+ Patients After a Waterbone Outbreak in Milwaukee," Gastroenterology, 104(4):A770 (abstr), 1994.
Blanshard and Gazzard, "Natural History and Prognosis of Diarrhoea of Unknown Cause in Patients with Acquired Immunodeficiency Syndrome (AIDS)", Gut, 36:283-286, 1995.
Gilson et al., "Impact of a Community-Wide Outbreak of Cryptosporidiosis on Patients with AIDS", Tenth International Conference of AIDS, 2:24 (abstr), 1994.
Fuller, "Probiotics in Man and Animals", Journal of Applied Bacteriology, 66:365-378, 1989.
Speck et al., "Lactobacillus reuteri in Food Supplementation," Food Technology, Jul.:90-94, 1993.
Axelsson, "Production of a Broad Spectrum Antimicrobial Substance by Lactobacillus reuteri", Microbial Ecology in Health and Disease, 2:131-136, 1989.
Chung et al., "In vitro Studies on Reuterin Synthesis by Lactobacillus reuten", Microbial Ecology in Health and Disease, 2:137-144, 1989.
Heine et al., "Persistent Cryptosporidium infectio in Congentially Athymic (Nude) Mice", Infection and Immunity, 43(3):856-859, 1984.
Harp et al., "Resistance of Severe Combined Immunodeficient Mice to Infection with Cryptosporidium parvuum: the importance of Intestinal Microflora", Infection and Immunity, 60(9):3509-3512, 1992.
Ungar et al., "New Mouse Models for Chronic Cryptosporidium Infection in Immunodeficient Hosts", Infection and Immunity, 58(4):961-969, 1990.
Alak et al., "Alcohol and Murine Acquired Immunodeficiency Syndrome Suppression of Resistance to Crytosporidum parvum Infection during Modulation of Cytokine Production", Alcoholism: Clinical and Experimental Research, 17(3): 539-544, 1993.
Darban et al., "Cryptosporidiosis Facilitated by Murine Retroviral Infection with LP-BM5", The Journal of Infectious Diseases, 164:741-745, 1991.
Famularo et al., "Effect of Lactobacill on Cryptosporidium parvuum Infection in Man and Animals", Microbial Ecoglogy in Health and Disease, 8(1):iii, 1995.
The Columbia Dispatch, "Government issues tap-water warning", Saturday, Jun. 17, 1995, p. 4A.
Lin and Savage, "Host specificity of the colonization of murine epithelium by lactobacilli", FEMS Microbiology Letters 24:67-71, 1984.
Wolf et al., "Safety and Tolerance of Lactobacillus reuteri in Healthy Adult Male Subjects", Microbial Ecology in Health and Disease, 8:41-50, 1995.
Goodgame et al., "Intensity of Infection in AIDS-Associated Cryptosporidiosis", The Journal of Infectious Diseases, 167:704-709, 1993.
Garleb Keith Allen
Wolf Bryan Warren
Abbott Laboratories
Brainard Thomas D.
Drayer Lonnie R.
Witz Jean C.
LandOfFree
Lactobacillus acidophilus to inhibit cryptosporidiosis in mammal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactobacillus acidophilus to inhibit cryptosporidiosis in mammal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactobacillus acidophilus to inhibit cryptosporidiosis in mammal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1511847